Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury

Simonetta Papa, Raffaele Ferrari, Massimiliano De Paola, Filippo Rossi, Alessandro Mariani, Ilaria Caron, Eliana Sammali, Marco Peviani, Valentina Dell'Oro, Claudio Colombo, Massimo Morbidelli, Gianluigi Forloni, Giuseppe Perale, Davide Moscatelli, Pietro Veglianese

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The possibility to control the fate of the cells responsible for secondary mechanisms following spinal cord injury (SCI) is one of the most relevant challenges to reduce the post traumatic degeneration of the spinal cord. In particular, microglia/macrophages associated inflammation appears to be a self-propelling mechanism which leads to progressive neurodegeneration and development of persisting pain state. In this study we analyzed the interactions between poly(methyl methacrylate) nanoparticles (PMMA-NPs) and microglia/macrophages in vitro and in vivo, characterizing the features that influence their internalization and ability to deliver drugs. The uptake mechanisms of PMMA-NPs were in-depth investigated, together with their possible toxic effects on microglia/macrophages. In addition, the possibility to deliver a mimetic drug within microglia/macrophages was characterized in vitro and in vivo. Drug-loaded polymeric NPs resulted to be a promising tool for the selective administration of pharmacological compounds in activated microglia/macrophages and thus potentially able to counteract relevant secondary inflammatory events in SCI.

Original languageEnglish
Pages (from-to)15-26
Number of pages12
JournalJournal of Controlled Release
Volume174
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Microglia
Spinal Cord Injuries
Nanoparticles
Macrophages
Polymethyl Methacrylate
Pharmaceutical Preparations
Aptitude
Poisons
Spinal Cord
Pharmacology
Inflammation
Pain
In Vitro Techniques

Keywords

  • Drug delivery
  • Macrophage
  • Microglia
  • Nanoparticle
  • Spinal cord injury

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury. / Papa, Simonetta; Ferrari, Raffaele; De Paola, Massimiliano; Rossi, Filippo; Mariani, Alessandro; Caron, Ilaria; Sammali, Eliana; Peviani, Marco; Dell'Oro, Valentina; Colombo, Claudio; Morbidelli, Massimo; Forloni, Gianluigi; Perale, Giuseppe; Moscatelli, Davide; Veglianese, Pietro.

In: Journal of Controlled Release, Vol. 174, No. 1, 2014, p. 15-26.

Research output: Contribution to journalArticle

Papa, S, Ferrari, R, De Paola, M, Rossi, F, Mariani, A, Caron, I, Sammali, E, Peviani, M, Dell'Oro, V, Colombo, C, Morbidelli, M, Forloni, G, Perale, G, Moscatelli, D & Veglianese, P 2014, 'Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury', Journal of Controlled Release, vol. 174, no. 1, pp. 15-26. https://doi.org/10.1016/j.jconrel.2013.11.001
Papa, Simonetta ; Ferrari, Raffaele ; De Paola, Massimiliano ; Rossi, Filippo ; Mariani, Alessandro ; Caron, Ilaria ; Sammali, Eliana ; Peviani, Marco ; Dell'Oro, Valentina ; Colombo, Claudio ; Morbidelli, Massimo ; Forloni, Gianluigi ; Perale, Giuseppe ; Moscatelli, Davide ; Veglianese, Pietro. / Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury. In: Journal of Controlled Release. 2014 ; Vol. 174, No. 1. pp. 15-26.
@article{b25747ced990462b92cb845277cc4b8f,
title = "Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury",
abstract = "The possibility to control the fate of the cells responsible for secondary mechanisms following spinal cord injury (SCI) is one of the most relevant challenges to reduce the post traumatic degeneration of the spinal cord. In particular, microglia/macrophages associated inflammation appears to be a self-propelling mechanism which leads to progressive neurodegeneration and development of persisting pain state. In this study we analyzed the interactions between poly(methyl methacrylate) nanoparticles (PMMA-NPs) and microglia/macrophages in vitro and in vivo, characterizing the features that influence their internalization and ability to deliver drugs. The uptake mechanisms of PMMA-NPs were in-depth investigated, together with their possible toxic effects on microglia/macrophages. In addition, the possibility to deliver a mimetic drug within microglia/macrophages was characterized in vitro and in vivo. Drug-loaded polymeric NPs resulted to be a promising tool for the selective administration of pharmacological compounds in activated microglia/macrophages and thus potentially able to counteract relevant secondary inflammatory events in SCI.",
keywords = "Drug delivery, Macrophage, Microglia, Nanoparticle, Spinal cord injury",
author = "Simonetta Papa and Raffaele Ferrari and {De Paola}, Massimiliano and Filippo Rossi and Alessandro Mariani and Ilaria Caron and Eliana Sammali and Marco Peviani and Valentina Dell'Oro and Claudio Colombo and Massimo Morbidelli and Gianluigi Forloni and Giuseppe Perale and Davide Moscatelli and Pietro Veglianese",
year = "2014",
doi = "10.1016/j.jconrel.2013.11.001",
language = "English",
volume = "174",
pages = "15--26",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury

AU - Papa, Simonetta

AU - Ferrari, Raffaele

AU - De Paola, Massimiliano

AU - Rossi, Filippo

AU - Mariani, Alessandro

AU - Caron, Ilaria

AU - Sammali, Eliana

AU - Peviani, Marco

AU - Dell'Oro, Valentina

AU - Colombo, Claudio

AU - Morbidelli, Massimo

AU - Forloni, Gianluigi

AU - Perale, Giuseppe

AU - Moscatelli, Davide

AU - Veglianese, Pietro

PY - 2014

Y1 - 2014

N2 - The possibility to control the fate of the cells responsible for secondary mechanisms following spinal cord injury (SCI) is one of the most relevant challenges to reduce the post traumatic degeneration of the spinal cord. In particular, microglia/macrophages associated inflammation appears to be a self-propelling mechanism which leads to progressive neurodegeneration and development of persisting pain state. In this study we analyzed the interactions between poly(methyl methacrylate) nanoparticles (PMMA-NPs) and microglia/macrophages in vitro and in vivo, characterizing the features that influence their internalization and ability to deliver drugs. The uptake mechanisms of PMMA-NPs were in-depth investigated, together with their possible toxic effects on microglia/macrophages. In addition, the possibility to deliver a mimetic drug within microglia/macrophages was characterized in vitro and in vivo. Drug-loaded polymeric NPs resulted to be a promising tool for the selective administration of pharmacological compounds in activated microglia/macrophages and thus potentially able to counteract relevant secondary inflammatory events in SCI.

AB - The possibility to control the fate of the cells responsible for secondary mechanisms following spinal cord injury (SCI) is one of the most relevant challenges to reduce the post traumatic degeneration of the spinal cord. In particular, microglia/macrophages associated inflammation appears to be a self-propelling mechanism which leads to progressive neurodegeneration and development of persisting pain state. In this study we analyzed the interactions between poly(methyl methacrylate) nanoparticles (PMMA-NPs) and microglia/macrophages in vitro and in vivo, characterizing the features that influence their internalization and ability to deliver drugs. The uptake mechanisms of PMMA-NPs were in-depth investigated, together with their possible toxic effects on microglia/macrophages. In addition, the possibility to deliver a mimetic drug within microglia/macrophages was characterized in vitro and in vivo. Drug-loaded polymeric NPs resulted to be a promising tool for the selective administration of pharmacological compounds in activated microglia/macrophages and thus potentially able to counteract relevant secondary inflammatory events in SCI.

KW - Drug delivery

KW - Macrophage

KW - Microglia

KW - Nanoparticle

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84888196375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888196375&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2013.11.001

DO - 10.1016/j.jconrel.2013.11.001

M3 - Article

C2 - 24225226

AN - SCOPUS:84888196375

VL - 174

SP - 15

EP - 26

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 1

ER -